Feasibility of SBIRT-PN

Not Applicable

Completed

• Conditions: Substance Use; HIV/AIDS; Infectious Disease; Older Adults; Behavioral Intervention

• Registration Number: NCT03057119
• Lead Sponsor: Florida State University

Brief Summary

Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.

Detailed Description

The current project will pilot SBIRT with a peer navigator (SBIRT-PN) versus treatment at usual (TAU) to increase substance use treatment engagement among HIV-positive adults aged 50 years and older. The investigators will recruit patients from the Southern HIV and Alcohol Research Consortium (SHARC) HIV primary care clinic network.

In order to develop effective substance use intervention models for HIV care settings the specific aims of the current project are:

Aim1: Examine the feasibility of the SBIRT-PN model at the UF Health Infectious Disease-Medical Specialties Clinic. The investigators hypothesize that the SBIRT-PN model will demonstrate high feasibility within the UF Health Infectious Disease - Medical Specialties Clinic.

Aim2a: Assess the acceptability of SBIRT-PN. The investigators hypothesize that SBIRT-PN will demonstrate high acceptability among patients enrolled in this condition.

Aim2b: Assess the acceptability of SBIRT-PN among HIV-positive individuals by age cohort (younger vs older). The investigators hypothesize that SBIRT-PN will demonstrate higher acceptability among older HIV-positive patients enrolled in this condition.

Aim3: Assess influence of SBIRT-PN model on treatment engagement and substance use compared to enhanced treatment as usual (TAU).The investigators hypothesize that those in the SBIRT-PN condition will evidence greater treatment engagement and a reduction in substance use.

Study Timeline

• Study First Submitted: 2017-02-15
• Study First Submitted QC: 2017-02-15
• Study First Posted: 2017-02-17
• Study Start: 2018-02-12
• Primary Completion: 2021-02-28
• Study Completion: 2022-03-31
• Results First Submitted: 2023-03-20
• Status Verified: 2023-09
• Results First Submitted QC: 2023-09-07
• Last Update Submitted: 2023-09-07
• Results First Posted: 2023-09-11
• Last Update Posted: 2023-09-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

• Receiving care at an Infectious disease Medical Clinic
• HIV-positive (seropositive confirmed by medical records)
• have a substance misuse screening score indicating moderate or high risk.

Exclusion Criteria

• lack fluency in English
• are unwilling to provide information for follow-up
• plan to leave the area within 6 months
• already have a referral to treatment from another provider
• unable to provide informed consent due to cognitive impairment.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number of Participants Ranking Intervention as Acceptable	30 Days	To examine ratings of acceptability, the investigators will use the overall acceptability score and percentage of acceptability. Overall acceptability will be assessed by summing ratings from the 10-item questionnaire to provide a total intervention acceptability score for the intervention, such that acceptability scores for the intervention could range from 10 (low acceptability) to 50 (high acceptability). The intervention will be considered to have acceptability if 80% of the participants rank the intervention as acceptable (i.e., 4 or higher) on 80% or more of the scale items. The investigators will then examine each question of the Acceptability Questionnaire separately to determine strengths and weaknesses of the intervention.

Secondary Outcome Measures

Name	Time	Method
Number of Participants Who Used Different Types of Substances (Self-Reported)	6 Months	A standard measure from the NIDA STTR Vulnerable Populations Data Harmonization tool kit will be used.
Number of Participants Who Obtained Formal Substance Use Treatment	6 Months	Participants will self-report if they obtained formal substance use treatment (i.e., any services sought to address substance use from individual therapy to 12 step fellowships). The investigators will request treatment facility information and permission to verify treatment. Once treatment has been verified, treatment engagement will be coded as 0= no formal treatment 1= formal treatment engagement
Number of Participants Who Used Different Types of Substances (Biologically Confirmed Via Urinalysis)	6 Months	A CLIA 12-Panel Instant Drug Test Cup (CLIAwaivedTM, San Diego, CA), which tests for the presence of 12 common substances in the urine will be used.

Trial Locations

Locations (3)

University of Florida; 🇺🇸 Gainesville, Florida, United States

CAN Community Health; 🇺🇸 Jacksonville, Florida, United States

Department of Health in Columbia County",; 🇺🇸 Lake City, Florida, United States